Ricrolin TE.E Stagnis499648585.mialojamiento.es/biblioteca/CROSSLINKING... · 45,13 ±0.97 46,12...
Transcript of Ricrolin TE.E Stagnis499648585.mialojamiento.es/biblioteca/CROSSLINKING... · 45,13 ±0.97 46,12...
08/04/2010
1
RICROLIN TERICROLIN TE
Barcelona 06.04.’10
• Absorption and concentration of UV radiation
• Photo-sensitizing agent: production of reactive oxygen species
RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)
08/04/2010
2
• Corneal endothelium and other eye structures protection (lens and retina)
RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)RIBOFLAVIN (VIT B2)
0,1% Riboflavin reduces UV intensity up to 95%.Without Riboflavin the UV absorption of almost 30% by the endothelium and 50% by the lens was measured
So, why RICROLIN TE?So, why RICROLIN TE?
Because:� It doesn’t need operating room� Corneal thickness < 400 µ� Easier technique � Pre treatment VA maintenance� Better patient compliance (children)
� No post-treatment pain� No complications derived from
disepithelization
08/04/2010
3
RiboflavinRiboflavinAbsorptionAbsorption
Epithelial barrierEpithelial barrier
Shield effectShield effect
Laser Laser intensityintensity
Dott. Stefano BaiocchiDott. Stefano Baiocchi
CORNEAL EPITHELIUMCORNEAL EPITHELIUM
1
10
100
1000
10000
100000
ribof
lavi
n (n
g/g
tissu
e)
0 5 15 *30
Exposure time(min)
Riboflavin concentration in cornea of treated patie nt
ng/g with epithelium
ng/g without
08/04/2010
4
�� BioBio--enhancerenhancer
�� FotoFoto--enhancerenhancer
Riboflavin e Dextran T500Riboflavin e Dextran T500
Trometamol (Tris -(hydroxymethyl)aminomethane) is an inert
aminoalcohol with low toxicity used to mitigate, in vitro and in
vivo, carbon dioxide and others acids, thanks to its buffer
action. It’s present in a large variety of products, i.e. cosmetics
and drugs, like buffer solution thanks to its intracellular and
extracellular alkalinizing action. Its side effects are extremely
rare; in fact, in literature, is reported only one case regarding
a periorbital dermatitis induced by a gel containing
trometamol.
So, trometamol is extremely well tolerated.
Nahas G G, Sutin K M, Fermon C et al. Guidelines for the treatment of acidaemia with THAM. Drugs 1998: 55:
191–224.
TrometamolTrometamol
08/04/2010
5
• Increase efficacy(Abdelkader H et al., AAPS PharmSciTech., 2007)
• Decrease toxicity(U.S. Pharmacopoeia, Vol. XXII)
• Improve pharmacokinetic, pharmacodynamic e biodisponibility (liposolubility)(Valles et al., Methods Find Exp Clin Pharmacol., 2006)
• Combined with EDTA allow the transit through the tight-junctions(Cover et al., Microbios, 68 1991)
TrometamolTrometamol
08/04/2010
6
08/04/2010
7
CE MarkedCE Marked
Group
TreatmentObservations
MeasurementsAssessment of corneal damage
I Ricrolin
30 µl drops every 3 min for 2 h
Slit-lamp evaluation and photographs before treatment, and immediately after the last eye drop instillation; then 12, 24 and 36 h.
Methylene blue will be used as dye to assess the corneal damage.II
Ricrolin TE
0
50
100
150
200
CTR RCL
*
Den
sito
met
ry(%
of c
ontr
ol)
Quantification of corneal riboflavin TE uptake was assessed by densitometry analysis. *p<0.05 vs.CTR
08/04/2010
8
Inclusion criteriaInclusion criteria
• 20 eyes of 20 patient (14 males e 6 females)• Age included between 12 and 42 years (mean age 27 years)
• Increasing Keratoconus I and II level (Amsler –Krumeich classification)
• Treated the eye with higher corneal curvature index e lower corneal thickness
• Contralateral eye used as control• Mean corneal thickness 412,9 micron
• Controls: T0, 7 days, 15 days, 1 month, 3, 6 and 9 months
• VA tested in conditions of natural miosis with LogMar ETDRS tables
• Instruments:– biomicroscopy– ultrasounds and optic pachimetry– corneal topography and aberrometry– corneal OCT– endothelial cells counter
Materials and methodsMaterials and methods
08/04/2010
9
Height 3 mm, diameter 12 mm (external) and 10.5 (inte rnal), basal flange of 2 mm.The cilinder, introduced under the eyelid edge and directly on the cornea, works as a blepharostat, holds Ricro lin TE down, protects limbus from UV rays.
Corneal Silicon RingCorneal Silicon Ring
• RICROLIN TE 2h before the treatment (1 drop every 10 minutes)
• Anaesthetic drops preservative free• Pilocarpine 1% drops• Corneal silicon ring• RICROLIN TE 15 min before UV, then every 3-5
min during UV exposure• CBM Vega (CSO) 6 steps of 5 min each
TechniqueTechnique
08/04/2010
10
• Ophthalmic office(no operating room)
• No surgical tissue
• Corneal washing with BSS• Artificial tears (jaluronic acid and aminoacids) • Antibiotic drops preservative free
TherapyTherapy
After 2 days At the end of treatment
08/04/2010
11
ResultsResults
VisusVisus
Pre CXL 1 month 3 months 6 months 9 months
CXL Controls CXL Controls CXL Controls CXL Controls CXL Cont rols
UCVA 0,71±0.12 0,84±0.23 0,49±0.12 0,81±0.18 0,40±0.15 0,80±0.09 0,36±0.19 0,85±0.10 0,36±0.07 0,88±0.13
BCVA 0,35±0.23 0,46±0.21 0,26±0.10 0,48±0.29 0,22±0.08 0,50±0.06 0,18±0.16 0,62±0.08 0,16±0.10 0.66±0.11
p<0.05
PachimetryPachimetryCXL
Pre: 412,9±21.5Post: 410,3 ±15.3
ControlsPre: 423,3±12.2Post: 409,0 ±16.5
data not statistically significants (p<0.05)
ResultsResults
Pre CXL 1 month 3 months 6 months 9 months
CXL Controls CXL Controls CXL Controls CXL Controls CXL Cont rols
Sim kS
51,02±1.10 51,12±1.02 49,05±0.92 51,10±1.04 48,65±0,89 51,42±0,96 47,82±0,78 51,40±0,92 47,85±0,71 51,32±1.13
Sim kF
45,13±0.97 46,12±0.99 44,46±1.03 46,12±0.65 44,13±0.89 46,52±0.91 44,57±1,11 46,74±0.71 47,85±0.84 46,23±0.50
Sim Cyl
5,89 4,91 4,59 4,98 4,55 4,91 3,32 4,70 3,55 5,12
p<0.05
Central keratometry (3 mm)Central keratometry (3 mm)
endothelial cells counter (cell/mmendothelial cells counter (cell/mm 22))CXL
Pre: 2427 ± 236.4Post: 2387 ± 361.0
ControlsPre: 2523 ± 198.2Post: 2474 ± 241.0
data not statistically significants (p<0.05)
08/04/2010
12
Pre CXL 1 month 3 months 6 months 9 months
CXL Controls CXL Controls CXL Controls CXL Controls CXL Cont rols
Kcak
59,12±1.10 58,89±2.02 58,01±0.92 58.92±2.34 57,42±0,89 59,43±1.87 57,31±0,78 59,86±2.45 57,56±1.21 60,06±1.13
Mc
56,46±0.97 56,31±1.93 55,73±1.41 56,29±2.18 55,52±0.89 57,02±0.91 55,49±1,11 57,59±2.02 55,51±1.23 58,18±0.93
Ma
23,89±0.75 21,91±2.05 20,07±2.42 21,98±1.67* 20,09±2.50 23,06±1.4 20,01±2.02 23,21±0.67 20,12±1.22 23,81±0.88
Maximal curvature (KcAK) Maximal curvature (KcAK) and CLMI indexes (Ma, Mc)and CLMI indexes (Ma, Mc)
ResultsResults
p<0.05 *p>0.05
Pre CXL 1 month 3 months 6 months 9 months
CXL Controls CXL Controls CXL Controls CXL Controls CXL Cont rols
Rms4,68±0.27 4,43±0.75 4,21±0.66 4,12±0.83 3,75±0,59 4,39±1.47 3,01±0,38 4,56±2.45 3,21±0.45 4,71±1.02
Coma
2,21±0.97 2,28±1.93 2,19±1.04 2,10±1.74 1,72±0.32 2,23±1.05 1,65±1,01 2,41±1.88 1,59±1.23 2,39±0.93
S.A.0,98±0.15 1,12±.052 0.77±0.42 1,08±0.67 0,45±0.59 1,26±0.72 0,45±0.39 1,26±0.47 0,35±0.64 1,31±0.98
p<0.05
ResultsResults
Corneal aberrometryCorneal aberrometry
08/04/2010
13
ResultsResults
corneal OCTcorneal OCT
1 month
Take home messageTake home message•• Better compliance of the patientBetter compliance of the patient (possibility to treat (possibility to treat
patients under 15 years old and ”complicated subject s”)patients under 15 years old and ”complicated subject s”)•• No postNo post--treatment paintreatment pain•• Corneal thickness < 380 micronCorneal thickness < 380 micron•• Pre treatment VA maintenancePre treatment VA maintenance•• Adjuvant treatment of “traditional CXL” Adjuvant treatment of “traditional CXL” (one technique (one technique
has the opportunity to reinforce the effectiveness of the has the opportunity to reinforce the effectiveness of the other)other)
08/04/2010
14
•• The The trans epithelial CXLtrans epithelial CXL treatment doesn’t need treatment doesn’t need operating roomoperating room
•• Corneal Silicon RingCorneal Silicon Ring works as a works as a blepharostatblepharostat , , increase the increase the contact timecontact time between Ricrolin TE between Ricrolin TE and corneal epithelium, and corneal epithelium, protects limbus and stem protects limbus and stem cellscells from UV raysfrom UV rays
Take home messageTake home message